SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-17-042981
Filing Date
2017-02-14
Accepted
2017-02-14 14:39:00
Documents
4
Effectiveness Date
2017-02-14

Document Format Files

Seq Description Document Type Size
1 DEFM14A d308459ddefm14a.htm DEFM14A 1764674
2 GRAPHIC g308459g38b79.jpg GRAPHIC 27659
3 GRAPHIC g308459prc1.jpg GRAPHIC 125919
4 GRAPHIC g308459prc2.jpg GRAPHIC 83036
  Complete submission text file 0001193125-17-042981.txt   2091794
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-35409 | Film No.: 17607270
SIC: 2834 Pharmaceutical Preparations